Viekira Pak Interactions
There are 719 drugs known to interact with Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir), along with 9 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 276 are major, 402 are moderate, and 41 are minor.
- View all 719 medications that may interact with Viekira Pak
- View Viekira Pak alcohol/food interactions (3)
- View Viekira Pak disease interactions (9)
Most frequently checked interactions
View interaction reports for Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir) and the medicines listed below.
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir disoproxil)
- acetylcysteine
- Actifed Cold & Sinus (acetaminophen / chlorpheniramine / pseudoephedrine)
- Adderall XR (amphetamine / dextroamphetamine)
- Afinitor Disperz (everolimus)
- Alcohol (contained in alcoholic beverages) (ethanol)
- alendronate
- alprazolam
- Ambien (zolpidem)
- Ambien CR (zolpidem)
- amitriptyline
- BeneFix (coagulation factor ix)
- bupropion
- Daklinza (daclatasvir)
- diltiazem
- Enbrel (etanercept)
- hydralazine
- Klonopin (clonazepam)
- losartan
- Metoprolol Succinate ER (metoprolol)
- Moderiba (ribavirin)
- omeprazole
- OxyContin (oxycodone)
- ribavirin
- Soliris (eculizumab)
- Suboxone (buprenorphine / naloxone)
- tramadol
- Valium (diazepam)
- Vyvanse (lisdexamfetamine)
- Xanax (alprazolam)
Viekira Pak alcohol/food interactions
There are 3 alcohol/food interactions with Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir).
Viekira Pak disease interactions
There are 9 disease interactions with Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir) which include:
- cirrhosis
- liver impairment
- immunosuppression
- hepatic dysfunction
- hemophilia
- hyperglycemia
- hyperlipidemia
- heart block
- hepatotoxicity
Report options
More about Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Viekira Pak consumer information
- Compare alternatives
- Reviews (13)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Mavyret
Mavyret is used to treat adults and children 3 years of age and older with acute or chronic ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Zepatier
Zepatier (elbasvir and grazoprevir) is used to treat chronic hepatitis C. Includes Zepatier side ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
